Ogier
Jean-Marc Ogier, Chatelaillon Plage FR
Patent application number | Description | Published |
---|---|---|
20160035060 | METHOD FOR WATERMARKING THE TEXT PORTION OF A DOCUMENT - A method for watermarking a document containing at least one text portion comprising the following steps: —determining a specific character font comprising, for at least one character, an original graphic and at least one variation, each of the variations being associated with a different value, said character being termed encodable characters; —using the specific character font to encode an item of information in the text portion of the document, by replacing at least one original graphic with a variation, the original graphic and the variation or variations being identified as a single character by a first optical character recognition process referred to as standard OCR and identified as a plurality of characters by a second optical character recognition process referred to as specific OCR that is capable of determining if the represented character is the original graphic or one of the variations of same and, if so, making it possible to determine the variation that is represented, a strict order relationship being defined on the encodable characters in order to establish the order in which the encodable characters are to be processed during the decoding phase. | 02-04-2016 |
Julien Ogier, Paris FR
Patent application number | Description | Published |
---|---|---|
20110105516 | POLYMERIZED MICELLES - Polymerised micelles comprising polymerised amphiphilic molecules obtained starting from amphiphilic molecules having one or two lipid chains each comprising one or two polymerisable moieties and linked to a polar head. | 05-05-2011 |
Richard G. Ogier, Half Moon Bay, CA US
Patent application number | Description | Published |
---|---|---|
20120002536 | INTERFERENCE MITIGATION AND ADAPTIVE ROUTING IN WIRELESS AD-HOC PACKET-SWITCHED NETWORKS - Described are an apparatus and method for routing packets through a multiple-hop wireless communications network. Interference with packet switched communications carried by radio frequency (RF) over the multiple-hop wireless communications network is detected. In response to information related to the detected interference, a route is adaptively determined for transmitting packets through the multiple-hop wireless communications network that mitigates the effect of the interference on the packets. | 01-05-2012 |
Simon Ogier, Ripon GB
Patent application number | Description | Published |
---|---|---|
20140097426 | TRANSISTORS - This invention comprises a field effect transistor which comprises source and drain electrodes ( | 04-10-2014 |
Simon Dominic Ogier, Bedale GB
Patent application number | Description | Published |
---|---|---|
20100108999 | PROCESS FOR PREPARING AN ELECTRONIC DEVICE - The invention relates to a process for preparing an electronic device using a protection layer, and to improved electronic devices prepared by this process, in particular organic field effect transistors (OFETs). | 05-06-2010 |
20100308304 | ELECTRONIC SHORT CHANNEL DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR FORMULATION - The invention relates to an improved electronic device, like an organic field emission transistor (OFET), which has a short source to drain channel length and contains an organic semiconducting formulation comprising a semiconducting binder. | 12-09-2010 |
Simon Dominic Ogier, Sowerby Bridge GB
Patent application number | Description | Published |
---|---|---|
20100227956 | Organic Semiconducting Layers - An organic semiconducting layer formulation containing an organic binder which has a permittivity, ε, at 1,000 Hz of 3.3 or less and a polyacene compound of Formula A: | 09-09-2010 |
Simon Dominic Ogier, Ripon GB
Patent application number | Description | Published |
---|---|---|
20140114040 | SEMICONDUCTOR COMPOUNDS - This invention comprises a semiconducting polymer having a permittivity greater than 3.4 at 1000 Hz and a charge mobility in the pure state greater than 10 | 04-24-2014 |
20140175409 | TRANSISTORS AND METHODS FOR MAKING THEM - A semiconductor composition which comprises a soluble polyacene semiconductor and a polymeric semiconducting binder the binder having a permittivity greater than 3.4 at 000 Hz. The charge mobility of the semiconducting binder when measured in a pure state is greater than 10 | 06-26-2014 |
Timothy J. Ogier, Alpena, AR US
Patent application number | Description | Published |
---|---|---|
20160136796 | FLANGE GASKET INSTALLATION APPARATUS AND METHOD - A gasket retaining apparatus and a method which uses the apparatus to install a gasket between a pair of flanges. The retaining apparatus includes a gasket holding element which is temporarily secured between the flanges while joining the flanges together. A gasket groove is formed in the forward edge of the gasket holding element and one or more bolting slots extend into the body of the holding element from the forward edge. The gasket holding element preferably also includes a pair of retention holes so that a pair of releasable locking pins can be inserted through a pair of the bolt holes of one of the flanges and into the retention holes to temporarily secure the gasket holding element during the installation process. | 05-19-2016 |
Virginie Ogier, Nancy FR
Patent application number | Description | Published |
---|---|---|
20090291091 | USE OF THE GLOBULAR DOMAIN OF ACRP30 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF THROMBOSIS-RELATED DISEASES - It is the object of the present invention to provide novel means for the treatment and/or prevention of thrombosis, tumor implantation, tumor seeding and metastasis. More specifically, the present invention relates to the use of a polypeptide comprising the globular head of Acrp30 for the manufacture of a medicament for treatment and/or prevention of thrombosis-related disorder, an hypertensive disorder of the pregnancy, tumor implantation, tumor seeding and metastasis. | 11-26-2009 |
20110097743 | COMPOSITIONS AND METHODS OF DETECTING TIABS - The present invention relates to novel methods and products for assessing the physiological status of a subject. More particularly, the invention relates to methods of assessing the presence, risk or stage of a cancer in a subject by measuring the levels of antibodies against particular aberrant protein domains in a sample from the subject, or the presence or number of immune cells bearing TCR specific for such aberrant protein domains. The invention is also suitable to assess the responsiveness of a subject to a treatment, as well as to screen candidate drugs and design novel therapies. The invention may be used in any mammalian subject, particularly in human subjects. | 04-28-2011 |
Walter Ogier, Winchester, MA US
Patent application number | Description | Published |
---|---|---|
20110300134 | REVERSE AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF - The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6. | 12-08-2011 |
20120083504 | Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof - The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6. | 04-05-2012 |
20120190693 | Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof - The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6. | 07-26-2012 |
20140142117 | REVERSE AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF - The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6. | 05-22-2014 |
20150045380 | REVERSE AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF - The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6. | 02-12-2015 |